Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

0.5228 -0.0283 (-5.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,972,202
Open 0.5500
Bid (Size) 0.5197 (5)
Ask (Size) 0.5200 (1)
Prev. Close 0.5511
Today's Range 0.5130 - 0.5599
52wk Range 0.5130 - 2.820
Shares Outstanding 210,356,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And... 
Via Benzinga
Inovio Pharmaceuticals (INO) Q1 2023 Earnings Call Transcript
INO earnings call for the period ending March 31, 2023. 
Via The Motley Fool

Performance

YTD
-65.61%
-65.61%
1 Month
-35.42%
-35.42%
3 Month
-53.73%
-53.73%
6 Month
-69.78%
-69.78%
1 Year
-68.32%
-68.32%

More News

Read More
Inovio Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
Via The Motley Fool
Why Inovio Pharmaceuticals' Shares Jumped on Thursday
Via The Motley Fool
Why Shares of Inovio Pharmaceuticals Were Down Tuesday
Via The Motley Fool
Earnings Scheduled For March 1, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Why Inovio (INO) Shares Are Moving After-Hours
Via Benzinga
2 Stocks to Sell or Remove From Your Watchlist in 2023
Via The Motley Fool
Coronavirus Vaccine Market To Surpass $95 Billion By 2028
Via FinancialNewsMedia
Exposures COVID-19
Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola
Via Benzinga
3 Sorry Pharma Stocks to Sell in February Before It’s Too Late
Via InvestorPlace
INOVIO Announces Further Reorganization, Continues Focus on Promising DNA Candidates
Via Benzinga
If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
Via Benzinga
Futu Holdings, UP Fintech Holding And Some Other Big Stocks Moving Lower On Friday
Via Benzinga
Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
Via Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Via Benzinga
Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs
Via Benzinga
3 Stocks to Avoid Right Now
Via The Motley Fool
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
Via FinancialNewsMedia
Exposures COVID-19
Why Inovio Pharmaceuticals Stock Is Popping Off
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.